The oncoprotein transcription factor Myc plays a crucial role in the control of cell growth and proliferation. Consistent with its potent growth-promoting properties, cells have evolved a number of mechanisms to limit the activity and accumulation of the Myc protein. One of the most striking of these mechanisms is ubiquitin (Ub)-mediated proteolysis, which typically destroys Myc within minutes of its synthesis. Here we show that, despite the extreme instability of the Myc protein, cells contain a pool of Myc that is metabolically stable. Entry of Myc into the stable pool is signaled by an element within the carboxy-terminus of the protein, and is a cell-specific process that is regulated during mitosis and by interaction with Max. These data demonstrate thateven for a rapidly turned-over protein such as Mycmetabolically stable and unstable forms of a protein can co-exist in cells, and suggest that the rate of destruction of Myc molecules is linked to their specific functions. Oncogene (2002) 21, 8515 -8520. doi:10.1038/sj.onc. 1205976
Myc is a basic helix -loop -helix transcription factor with potent growth-promoting and transforming capabilities (Henriksson and Luscher, 1996; Land et al., 1983) . Accordingly, normal cells contain very low levels of Myc -typically as few as 6000 molecules per cell (Rudolph et al., 1999) . Numerous mechanisms have evolved to restrict the accumulation and activity of the Myc protein, one of the most striking of which is proteolysis. Indeed, Myc is a very unstable protein, with a typical half-life of *30 min (Hann and Eisenman, 1984) . Like many proteins involved in the control of cell growth, Myc is destroyed by ubiquitin (Ub)-mediated proteolysis (Ciechanover et al., 1991; Salghetti et al., 1999) , a process in which substrate proteins are tagged by covalent linkage to ubiquitin and subsequently destroyed by the proteasome (Varshavsky, 1997) . The importance of Myc proteolysis to cellular growth control is underscored by the fact that cancer-associated and transforming mutations within Myc block its destruction Salghetti et al., 1999) , allowing Myc to accumulate.
Despite evidence that Myc is a highly unstable protein, we have consistently observed, in pulse-chase experiments (Figure 1a) , that the rate of decay of transiently-expressed Myc is not constant. Specifically, there is an initial phase in which Myc decays quite rapidly (half-life *20 min), followed by a latter phase in which Myc destruction is slow (half-life *2 h). We reasoned that this 'biphasic decay' is due to the presence of two distinct pools of Myc protein: one that is being turned-over quickly, and another that is metabolically stable. To test this model, we asked if we could separate Myc into two pools by differential detergent extraction (Figure 1b ). HeLa cells, transiently expressing Myc, were pulse-labeled by exposure to 35 S-methonine, and labeled proteins were fractionated into detergent extractable ('S1') and non-extractable ('S2') pools. Myc was then recovered from each pool by immunoprecipitation. We found that Myc is partitioned into both pools, but the kinetics of Myc decay in each pool is very different (Figure 1b, graph) . In S1, Myc decays quickly and with first-order kinetics, displaying a constant half-life of *18 min. In S2, however, Myc is much more stable, with an apparent half-life of *2 h. This behavior is not an artifact of transient Myc over-expression, because analysis of endogenous Myc in HeLa cells gave similar results (Figure 1c) . The ability to separate Myc into these two pools demonstrates that the biphasic decay of Myc results from the co-existence of two metabolically distinct populations of Myc protein. Moreover, the results reveal that -despite the rapid turnover of the majority of Myc -a significant percentage of Myc escapes rapid proteasomal destruction.
To characterize the two pools of Myc further, we probed the S1 and S2 fractions with antibodies against a variety of cellular proteins -MEK2, which localizes exclusively to the cytoplasm (Mendez and Stillman, 2000) , the general transcription factors TBP and TFIIB, nuclear proteins that functionally interact with chromatin, and histone H3, a core component of chromatin itself (Figure 1d ). We found that MEK2 is contained exclusively in the S1 pool, whereas histone H3 resides exclusively within S2. TBP and TFIIB, however, partition between both pools; between 5 and 10% of TBP and TFIIB accumulate in the S2 pool, a level comparable to that seen with Myc. The differential partitioning of these cellular markers suggests that the S2 pool is enriched in chromatin, and that partitioning into S2 may be a general feature of transcriptional regulators.
To explore the basis of the stabilization of Myc in S2, we next asked whether Myc is differentially ubiquitylated between the two pools. We used the polyhistidine-tagged Ub method (Treier et al., 1994) to (Salghetti et al., 1999) , subjected to pulse-chase analysis, and total labeled HA-tagged Myc proteins recovered by denaturing immunoprecipitation with the 12CA5 monoclonal antibody (Salghetti et al., 1999 , and incubated at 48C for 1 h. Cell lysates were fractionated by brief centrifugation (16 000 g for 5 min), giving rise to the soluble (S1) and insoluble (S2) pools. Labeled Myc proteins present in each pool were recovered by immunoprecipitation with 12CA5. (c) Endogenous Myc partitions into two pools. Untransfected HeLa cells were subject to pulse-chase analysis as described. At each time point, cells were harvested and separated into two aliquots. One aliquot was used for the isolation of total labeled proteins. The other aliquot was used for RIPA fractionation. Labeled Myc proteins present in the total, S1, and S2 pools were recovered using the anti -Myc antibody N262 (Santa Cruz). (d) The S2 fraction is enriched in chromatin. Untransfected HeLa cells were fractionated into S1 and S2 pools and proteins present in the total (T), S1, and S2 pools detected by Western blotting. Antibodies against TBP and TFIIB were provided by Nouria Hernandez. The anti-histone H3 and MEK2 antibodies were purchased from Upstate and Transduction Laboratories, respectively. (e) Myc in S2 is ubiquitylated. To detect ubiquitylated proteins, the His 6 -tagged Ub method (Treier et al., 1994) was used. Western blots show the distribution of ubiquitylated Myc proteins between the total, S1, and S2 pools, either alone ('7Ub H '), or in the presence of polyhistidine-tagged human Ub ('+Ub H '). The bracketed smear indicates ubiquitylated Myc proteins ('Ub -Myc'). Lanes 7 and 8 are a longer exposure of the image from lanes 5 and 6. (f) Most ubiquitlyated proteins are present in the S1 pool. Western blot of the samples used in (e), showing the distribution of total ubiquitylated proteins in each pool, as detected by an anti-His-Tag antibody (Novagen) detect ubiquitylated Myc proteins present in the total, S1, and S2 fractions ( Figure 1e ). As reported previously (Salghetti et al., 1999) , Myc extracted from total cell lysates is efficiently ubiquitylated (lane 4). When we compared Myc ubiquitylation in the S1 and S2 pools, however, we found that the majority of ubiquitylated Myc is present in the S2 pool (compare lanes 7 and 8). The accumulation of ubiquitylated Myc in S2 is in stark contrast to the bulk of ubiquitylated proteins, which are present in S1 (Figure 1f , compare lanes 5 and 6). Thus despite its stability, Myc present in S2 is efficiently ubiquitylated, suggesting that the stabilization of Myc in this pool results from a postubiquitylation block to Myc destruction.
Next, we asked whether a specific element is required for entry of Myc into the S2 pool. We generated a set of scanning deletion mutants ('DA -DG') in which we successively removed *63 amino acid segments of the Myc protein, transiently expressed these mutants in HeLa cells, and measured their partitioning by immunoblotting (Figure 2a ). Wild-type Myc and the DA -DE deletion mutants were distributed in both the S1 and S2 pools. The DF and DG mutants, however, were restricted almost entirely to the S1 pool, despite the fact that both proteins were distributed throughout the nucleus (Figure 2b and data not shown). This result demonstrates that carboxy-terminal Myc sequences 316 -439 (spanning the DF and DG deletions) play an essential role in Myc partitioning into the S2 fraction.
To learn more about the basis for this partitioning, we next performed immunofluorescence analysis to compare the localization of wild-type Myc (present in both S1 and S2) with the DG mutant (present in S1 only; Figure 2b ). When expressed individually in HeLa cells, the two Myc proteins displayed very similar patterns of nuclear distribution (panels 1 and 2). To ask if these patterns were identical, we co-expressed these two proteins and used differential antibody staining to determine their location in the same cell (panels 3 -5). Confocal microscopy revealed that the distribution of these Myc proteins is perfectly coincident (panel 5). This result demonstrates that the inability of DG to enter S2 is not due to its mislocalization, and implies that partitioning of Myc into the S1 and S2 pools is the result of subtle differences that affect Myc's interaction with the nuclear environment.
We next asked if carboxy-terminal Myc sequences are sufficient to signal entry into the S2 pool. Residues 294 -439 of Myc were fused to the GAL4 DNAbinding domain (DBD) and the chimeric protein Twenty-four hours after transfection, cells were harvested and fractionated into total (T), S1, and S2 pools. Equivalent amounts of protein from each fraction were resolved by SDS -PAGE and detected by immunoblotting using 12CA5. (b) Wild-type Myc and the DG deletion mutant have overlapping nuclear distribution. Hela cells, growing on coverslips, were transfected with 100 ng of expression constructs encoding T7-epitope-tagged Myc, or HA-tagged Myc DG mutant. Twenty-four hours after transfection, cells were fixed with paraformaldehyde and immunofluorescence performed (Sacco-Bubulya and Spector, 2002) . The 12CA5 antibody was used to detect HA-tagged MycDG protein; the anti-Myc antibody 680 (Salghetti et al., 1999) , which recognizes an epitope deleted in the DG mutant, was used to visualize wild-type Myc. Images were acquired on a Zeiss LSM410 confocal laser scanning microscope. Shown is the distribution of wild-type (red) and DG (green) Myc, expressed either alone (panels 1 and 2), or together (panels 3 -5). The codistribution of these mutants is shown in yellow in panel 5. (c) The carboxy-terminus of Myc is sufficient to confer S2 entry. Hela cells were transfected with 100 ng of either pCG -GAL(1 -94) or pCG -GAL(1 -94) -Myc (294 -439) (Salghetti et al., 1999) . Twenty-four hours after transfection, cells were harvested, and fractionated into total, S1, and S2 pools. Shown are Western blots (12CA5) demonstrating the steady-state levels of GAL4 (1 -94) alone ('D'), or GAL4 fused to the carboxy-terminus of Myc ('Myc(294 -439)'). (d) Entry into the S2 pool is sufficient to confer protein stability. HeLa cells were transfected as in (c) and pulse-chase analysis performed to compare the stability of GAL4 (1 -94), GAL4 Myc(1 -128) (Salghetti et al., 1999) , and GAL4 Myc [294 -439] in the S1 and S2 pools expressed in HeLa cells. The GAL4 DBD did not enter S2, nor did GAL4 fused to the amino-terminus of the Myc protein (Figures 2c,d ). When residues 294 -439 of Myc were fused to the carboxy-terminus of Myc, however, greater than 70% of the fusion protein accumulated in the S2 fraction (Figure 2c, lane 6) . Importantly, entry of GAL4-Myc into S2 was accompanied by an increase in the metabolic stability of the protein (Figure 2d ): the half-life of GAL4 -Myc in S1 is *50 min, compared with over 200 min for the same protein in S2. Together, these data show that the carboxy-terminus of Myc is sufficient to confer entry of a protein into the S2 pool, and that entry into this pool is, in turn, sufficient to confer protein stability.
Because the carboxy-terminus of Myc interacts with partner proteins such as Max (Blackwood and Eisenman, 1991) and Miz-1 (Peukert et al., 1997) , we next asked whether these proteins affect Myc partitioning (Figure 3a) . Co-expression of Myc with Miz-1 did not block entry of Myc into S2 (lanes 4 -6), although it did promote the accumulation of Myc in S1 (compare lanes 2 and 5), consistent with our observation that Miz-1 stabilizes Myc (Salghetti et al., 1999) . Expression of Max, however, blocked the accumulation of Myc in S2 (lane 9). This effect of Max is direct, because the D412 -434 Myc mutant, which does not associate with Max (Peukert et al., 1997) , does not respond to Max expression (D412 -434, compare lanes 3 and 9). To determine the mechanism through which Max blocks accumulation of Myc in S2, we performed pulse-chase analysis (Figure 3b ). This experiment showed that Max expression has two effects -it reduces the amount of newly synthesized Myc present in S2 (compared to Myc alone), and it decreases the half-life of Myc in that fraction to *45 min. Because the reduced stability of Myc in S2 would also reduce levels of Myc in that fraction, we conclude that the predominant function of Max is to destabilize Myc in the S2 pool.
The extractability of Myc from cells is an issue that has received much attention in the past, most notably Myc's association with the nuclear matrix (Evan and Hancock, 1985) . It is tempting to speculate that Myc present in S2 is matrix-associated. This, however, is not the case, because the DG Myc mutant, which does not enter S2, efficiently associates with the nuclear matrix during standard preparation procedures (data not shown). Furthermore, it has been argued that nuclear matrix association is predominantly an ex vivo artifact of the extraction process (Hancock, 2000) . Our data, however, demonstrates conclusively that the stable form of Myc is not an artifact of extraction, because pulse-chase analysis labels proteins in intact cells, prior to their isolation. Thus it appears that Myc present in S2 is not nuclear matrix-associated, but rather some (Salghetti et al., 1999) , (iii) pCGT Max, which encodes T7 epitope-tagged Max (unpublished), and (iv) pCGT Miz-1, which encodes T7 epitope-tagged Miz-1 (unpublished). Following transfection, cells were harvested and fractionated into total, S1 and S2 pools. Shown are immunoblots probed with 12CA5 to detect HA-tagged Myc proteins. Samples were also probed with an anti-T7 tag antibody (Novagen) to confirm expression of Miz and Max (data not shown). (b) Max destabilizes Myc in S2. Cells were transfected with the appropriate Myc and Max expression constructs. Pulse-chase analysis was used to measure the stability of Myc in the S1, and S2 pools, either alone (lanes 1 -4) , or in the presence of ectopic Max (lanes 5 -8). (c) Mitotic arrest promotes accumulation of Myc S2. Transfected HeLa cells were treated overnight with 50 ng/ml nocodazole and mitotic cells collected by 'shake-off' (Carrano et al., 1999) , before preparation of the S1 and S2 fractions. Shown is the distribution of transfected Myc in either asynchronous cultures ('Asn'), or cultures arrested at mitosis by nocodazole ('Mitotic'). Total Myc proteins were detected by 12CA5; phosporylated Myc proteins ('P-Myc') were detected by a T58/S62 phosphorylation-specific antibody (Cell Signaling Technology) other form of Myc that is tightly associated with the nucleus. We speculate that the S2 form of Myc is chromatin-associated because it is dependent on the DNA-binding domain of Myc (Figure 2 ) and because the S2 fraction contains other chromatin-associated proteins such as histone H3 (Figure 1d ). We further suggest that Max-mediated destabilization of Myc occurs on the chromatin, and perhaps within the context of direct association with the DNA. This is an intriguing possibility, and not without precedent. Proteolysis of the transcription factor MyoD, for example, is stimulated by DNA-binding (Abu Hatoum et al., 1998) , and the destruction of synthetic activators has been shown to require a DNA-binding domain (Molinari et al., 1999) . Moreover, both the CDKinhibitor Xic1 (Furstenthal et al., 2001) , and Orc1, a subunit of the origin recognition complex (Mendez et al., 2002) , are ubiquitylated on the chromatin. Given the intimate relationship between transcriptional activation and activator destruction (Salghetti et al., 2000 (Salghetti et al., , 2001 , we suggest that the ability of Max to destabilize Myc in the S2 pool is due to its ability to associate with Myc and to allow Myc to activate target gene expression.
Recent studies have demonstrated that phosphorylation of Myc residues T58 and S62 -which are targets for Ras-induced stabilization of Myc (Sears et al., 2000) -dramatically increases as cells enter mitosis (Niklinski et al., 2000) . To determine if Myc partitioning is also regulated during mitosis, transfected HeLa cells were arrested at mitosis by treatment with nocodazole, and collected by 'mitotic shake-off' (Figure  3c ). We found that Myc partitioning is sensitive to nocodazole treatment, with the majority of Myc accumulating in the S2 pool during mitotic arrest ('Myc', compare lanes 3 and 4 with 6 and 7). This effect was even more pronounced when we examined distribution of the T58/S62 form of Myc, using phospho-specific antibodies ('P-Myc', compare lanes 3 and 4 with 6 and 7). Although we have not ruled out the possibility that this effect is an indirect result of drug treatment, these data are consistent with a model in which the partitioning of Myc between the S1 and S2 pools is regulated as cells enter mitosis. Perhaps the shutdown in transcriptional activation that occurs during mitosis (Prescott and Bender, 1962 ) is responsible for this transient stabilization of Myc protein.
Finally, we examined Myc partitioning in a number of different cell lines, including the colon carcinoma cell line Colo320 HSR (Hann and Eisenman, 1984) , and the Burkitt's lymphoma lines Namalwa, Manca, and Raji (Hann and Eisenman, 1984) . Similar to HeLa cells, Colo320 HSR cells (Figure 4a ) contained approximately 3% of endogenous, newly-synthesized, Myc in the stable S2 pool. However, we did not detect the S2 form of Myc in Namalwa cells (Figure 4b ), nor in any of the other Burkitt's lymphoma lines tested (data not shown). These data thus demonstrate that Myc is partitioned into the S2 pool in a cell-specific manner. We do not currently understand the basis for this cell-specificity. However, the absence of the S2 form of Myc in Namalwa, Manca, and Raji cells demonstrates that partitioning of Myc into the S2 pool is not simply a consequence of Myc overexpression, but rather a response of Myc to a particular cellular environment. The finding that all three Burkitt's lymphoma lines lack an S2 form of Myc suggests that the ability of Myc to enter S2 may be specifically affected in this cancer.
In summary, we have found that cells contain two pools of Myc protein -one that is turned over rapidly and another that is metabolically stable. The S2 form of Myc appears to be stabilized via a post-ubiquitylation mechanism signaled by sequences within the carboxy-terminus of the protein. The finding that different populations of Myc are targeted for destruction with different efficiencies provides a paradigm for understanding how populations of molecules are destroyed by the Ub-proteasome pathway and suggests that the rate of destruction of individual Myc proteins is tied to their specific interactions and activities within the cell. Figure 4 The distribution of Myc into the S1 and S2 pools is cell-specific. Pulse-chase analysis, showing the rate of decay of endogenous Myc in the colon carcinoma cell line Colo320 HSR ('Colo320') and the Burkitt's lymphoma cell line Namalwa Herbst, S Kim, Y Lazebnik, M Muratani and S Muthuswamy for discussions and critical comments on the manuscript. WP Tansey is a Leukemia and Lymphoma Society of America Scholar. KA Tworkowski is supported by training grant NIGMS-NIH 1T32-GM08468. This work was supported by the CSHL Cancer Center Support Grant CA45508 and by US Public Health Service grant CA-13106 from the National Cancer Institute.
